Explore current and emerging treatments for multiple myeloma in this informative community lecture featuring UCLA hematologist and oncologist Dr. Sarah M. Larson. Moderated by Leila Evangelista from the Leukemia & Lymphoma Society, the talk covers a wide range of topics including the immune system, plasma cells, M protein, disease spectrum, and CRAB criteria. Delve into various treatment approaches, response rates, and the concept of minimal residual disease. Learn about cutting-edge therapies such as Venetoclax, immunotherapy targeting BCMA and BLEN, and CAR T-cell treatments, including their side effects and ongoing clinical trials. Gain insights into the latest research, including the Storm, Karma 3, and Karma 4 trials, and discover efforts to design more effective CAR T-cells. The lecture concludes with information on clinical trials and the Climb to Cure initiative, followed by a Q&A session.